Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2000;31:1194-1198

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosenblum, W. I.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Rosenblum, W. I.
Related Collections
Right arrow Acute Cerebral Infarction
Right arrow Brain Circulation and Metabolism
Right arrow Doppler ultrasound, Transcranial Doppler etc.

(Stroke. 2000;31:1194.)
© 2000 American Heart Association, Inc.


Letters to the Editor

Failure of Standards in Reporting the Composition of Artificial Cerebral Spinal Fluid in Studies of the Pial Blood Vessels

William I. Rosenblum, MD

Department of Pathology, Medical College of Virginia, at Virginia Commonwealth University, Richmond, Virginia


Key Words: cerebral vessels • cerebrospinal fluid • animal models

To the Editor:

Reproducible experimental results require the replication of the experimental conditions under which the experiment was first performed. Relevance to humans may depend on the degree to which those conditions resembled those to which humans are exposed. With respect to studies of vascular reactivity, a most important parameter is the composition of the fluid bathing the vessel. For vessels on the brains surface, so-called pial vessels, this fluid is the cerebrospinal fluid (CSF). Experiments studying these vessel, in vivo or in vitro, generally bathe the vessels in an artificial CSF, sometimes called a "mock" CSF, or some other fluid, sometimes called a physiological salt solution and sometimes simply a buffered solution. A question that should immediately arise, if relevance to humans is an issue, is whether the fluid used has the composition of cerebrospinal fluid, and if so, is it the composition of the experimental species’ CSF or of human CSF. At present there is no data to tell us whether or not it would be better to always replicate the composition of human CSF, even if this differs from that of the animal in use, or whether, instead, the mock CSF should resemble that of the animal itself. CSF contains urea, but not everyone adds urea to the artificial CSF, and there are no studies showing the effect of the urea on the vascular responses. Indeed there is virtually no information on the effect of altering one or more aspects of CSF composition, other than pH and . . . [Full Text of this Article]